TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector - PubMed (original) (raw)

TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector

S P Wu et al. J Cell Biol. 1992 Jan.

Abstract

Transforming growth factor-beta 1 (TGF-beta 1) has previously been implicated as a potential negative autocrine or paracrine growth regulator of certain cell types (Arteaga, C. L., R. J. Coffey, Jr., T. C. Dugger, C. M. McCutchen, H. L. Moses, and R. M. Lyons. 1990. Cell Growth & Differ. 1:367-374; Hafez, M. M., D. Infante, S. Winawer, and E. Friedman. 1990. Cell Growth & Differ. 1:617-626; Glick, A. B., K. C. Flanders, D. Danielpour, S. H. Yuspa, and M. B. Sporn. 1989. Cell Regulation. 1:87-97). This is based mainly on experiments assessing the effects of exogenous TGF-beta 1 or neutralizing antibodies to TGF-beta 1 on normal or tumor cell proliferation in vitro. However, direct evidence demonstrating such a negative regulation of tumor cell growth in vivo is still lacking. To overcome this problem we have constructed and used an antisense expression vector for TGF-beta 1 as a means of regulating endogenous TGF-beta 1 expression in tumor cells. Antisense-transfected FET human colon carcinoma cells showed a fivefold reduction in TGF-beta 1 mRNA and 15-fold reduction in TGF-beta 1 secretion. Antisense mRNA was detected in transfected cells by an RNase protection assay. Compared to control cells, cultured antisense-transfected cells showed a reduction in lag phase time rather than a change in doubling time. Cloning efficiencies of transfected cells were four times greater than control cells in anchorage-independent assays. Control cells did not form tumors at 5 x 10(5) in athymic nude mice. Antisense-transfected cells formed tumors in 40% of animals injected. At higher inocula (1 x 10(6) cells) antisense-transfected cells formed tumors in 100% of animals injected, but control cells still failed to form tumors. These results show that TGF-beta 1 acts as a negative growth regulator of human colon carcinoma cells in vivo as well as in vitro. Acquisition of partial or full resistance to such inhibitory effects may therefore contribute to tumor development and progression.

PubMed Disclaimer

Cited by

HLTF gene silencing in human colon cancer.
Moinova HR, Chen WD, Shen L, Smiraglia D, Olechnowicz J, Ravi L, Kasturi L, Myeroff L, Plass C, Parsons R, Minna J, Willson JK, Green SB, Issa JP, Markowitz SD. Moinova HR, et al. Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4562-7. doi: 10.1073/pnas.062459899. Epub 2002 Mar 19. Proc Natl Acad Sci U S A. 2002. PMID: 11904375 Free PMC article.
Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.
Lu C, Kerbel RS. Lu C, et al. J Cell Biol. 1993 Mar;120(5):1281-8. doi: 10.1083/jcb.120.5.1281. J Cell Biol. 1993. PMID: 8436594 Free PMC article.
Dysregulation of autocrine TGF-beta isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts.
Fahey MS, Paterson IC, Stone A, Collier AJ, Heung YL, Davies M, Patel V, Parkinson EK, Prime SS. Fahey MS, et al. Br J Cancer. 1996 Oct;74(7):1074-80. doi: 10.1038/bjc.1996.492. Br J Cancer. 1996. PMID: 8855977 Free PMC article.
Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.
Darley R, Morris A, Passas J, Bateman W. Darley R, et al. Cancer Immunol Immunother. 1993 Jul;37(2):112-8. doi: 10.1007/BF01517043. Cancer Immunol Immunother. 1993. PMID: 8100485 Free PMC article.
Enhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cells.
Arrick BA, Grendell RL, Griffin LA. Arrick BA, et al. Mol Cell Biol. 1994 Jan;14(1):619-28. doi: 10.1128/mcb.14.1.619-628.1994. Mol Cell Biol. 1994. PMID: 8264630 Free PMC article.

References

1. Int J Cancer. 1988 Jul 15;42(1):64-70 - PubMed
1. Mol Endocrinol. 1989 Aug;3(8):1215-22 - PubMed
1. Cancer Lett. 1988 Dec 1;43(1-2):139-43 - PubMed
1. Science. 1989 Feb 17;243(4893):947-50 - PubMed
1. Cancer Res. 1988 Apr 1;48(7):1936-42 - PubMed

TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector - PubMed (original) (raw)